Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZZEF1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZZEF1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZZEF1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZZEF1 mRNA | CTD | PMID:32145629 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZZEF1 mRNA | CTD | PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-methylcholine | affects expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ZZEF1 mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZZEF1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZZEF1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZZEF1 mRNA | CTD | PMID:28628672 | aflatoxin B1 | increases methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ZZEF1 intron | CTD | PMID:30157460 | aristolochic acid A | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ZZEF1 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ZZEF1 mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of ZZEF1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ZZEF1 mRNA | CTD | PMID:26238291 | benzo[a]pyrene | affects methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZZEF1 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ZZEF1 3' UTR | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ZZEF1 intron | CTD | PMID:30157460 | bisphenol A | affects expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ZZEF1 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of ZZEF1 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZZEF1 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZZEF1 mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZZEF1 mRNA | CTD | PMID:28628672 | cadmium dichloride | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of ZZEF1 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of ZZEF1 protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZZEF1 gene] | CTD | PMID:28238834 | cisplatin | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ZZEF1 mRNA | CTD | PMID:27392435 and PMID:27594783 | cisplatin | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [jinfukang results in decreased expression of ZZEF1 mRNA] and jinfukang promotes the reaction [Cisplatin results in decreased expression of ZZEF1 mRNA] | CTD | PMID:27392435 | clobetasol | decreases expression | EXP | | 6480464 | Clobetasol results in decreased expression of ZZEF1 mRNA | CTD | PMID:27462272 | cobalt dichloride | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of ZZEF1 mRNA | CTD | PMID:19376846 | coumarin | increases phosphorylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of ZZEF1 protein | CTD | PMID:35688186 | cyclophosphamide | increases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Cyclophosphamide results in increased expression of ZZEF1 mRNA | CTD | PMID:27281708 | dexamethasone | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZZEF1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZZEF1 mRNA | CTD | PMID:28628672 | elemental selenium | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Selenium results in increased expression of ZZEF1 mRNA | CTD | PMID:19244175 | elemental selenium | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA | CTD | PMID:19244175 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of ZZEF1 mRNA | CTD | PMID:35436446 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of ZZEF1 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of ZZEF1 mRNA | CTD | PMID:30307764 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of ZZEF1 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZZEF1 mRNA | CTD | PMID:22206623 | indometacin | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZZEF1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZZEF1 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ZZEF1 protein | CTD | PMID:32959892 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of ZZEF1 mRNA | CTD | PMID:26307267 | methapyrilene | increases methylation | ISO | ZZEF1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ZZEF1 intron | CTD | PMID:30157460 | methotrexate | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of ZZEF1 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ZZEF1 mRNA | CTD | PMID:23649840 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of ZZEF1 mRNA | CTD | PMID:17475336 | ozone | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZZEF1 mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ZZEF1 mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZZEF1 mRNA | CTD | PMID:36331819 | selenium atom | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Selenium results in increased expression of ZZEF1 mRNA | CTD | PMID:19244175 | selenium atom | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA | CTD | PMID:19244175 | sunitinib | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ZZEF1 mRNA | CTD | PMID:31533062 | thioacetamide | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ZZEF1 mRNA | CTD | PMID:23411599 | toluene | increases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Toluene results in increased expression of ZZEF1 mRNA | CTD | PMID:22967744 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ZZEF1 mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ZZEF1 mRNA | CTD | PMID:23179753 | valproic acid | affects splicing | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of ZZEF1 mRNA | CTD | PMID:29427782 | valproic acid | decreases expression | ISO | Zzef1 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of ZZEF1 mRNA | CTD | PMID:29427782 | vitamin E | multiple interactions | ISO | ZZEF1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA | CTD | PMID:19244175 | vitamin E | decreases expression | ISO | ZZEF1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of ZZEF1 mRNA | CTD | PMID:19244175 | |